Wilmington, Del., Nov. 9, 2023 (GLOBE NEWSWIRE) — According to reports rational statisticsof The latest industry analysis shows that Global Hepatitis B vaccine (recombinant) market The value is estimated to be $6.5 billion in 2023 and is expected to rise strongly The compound annual growth rate exceeds 5.6% The forecast period is 2023 to 2030.
Market Definition, Market Scope and Report Overview
Hepatitis B vaccine (recombinant) is a vaccination used to prevent infection with hepatitis B virus (HBV). It contains a small, harmless portion of the hepatitis B virus (called a recombinant surface antigen) that stimulates the immune system to produce antibodies against the virus.
Hepatitis B is a dangerous and sometimes fatal viral infection of the liver. The most effective way to prevent hepatitis B infection is vaccination. As global awareness of the disease and its prevention techniques continues to increase, so does the need for a hepatitis B vaccine.
- Global Hepatitis B Vaccine (Recombinant) Market analyzed based on in-depth market assessment by RationalStat Based on market segments including type, application, distribution channel and geography/region (Including North America, Latin America, Western Europe, Eastern Europe, Middle East and Africa, Asia Pacific). The report also provides global and regional market size for the historical period 2019-2022 and the forecast period 2023-2030.
- Market intelligence for the global Hepatitis B Vaccine (Recombinant) market covers market size based on market value (USD Million/EUR Million) and volume (Units), demand assessment across key regions, customers based on various products/services/devices Sentiment, price points, cost structures, profit analysis across the value chain, financial assessment, historical and forecast data, key developments across the industry, import-export data, trade profiles, spare parts market by leading companies, and more.
- Additionally, long-term industry and product/service 10-year outlook and its impact on the global Hepatitis B Vaccine (Recombinant) market. It also includes the current status of the industry—production levels, capacity utilization, technology vendors, etc. Key information includes manufacturing capacity, installed capacity, imports, market size, key players, market size, dynamics, market data, insights, etc. by country.
Request customization- https://store.rationalstat.com/store/global-hepatitis-b-vaccine-recombinant-market/#tab-ux_global_tab
Global Hepatitis B Vaccine (Recombinant) Market: Segmentation and Market Share Analysis
- In terms of distribution channel, the hospital segment held the highest market share in 2022 owing to the large volume of product sales to hospitals.
- The neonatal/pediatric segment is expected to dominate the global market based on application as the first dose of vaccine administered to newborns before hospital discharge.
Report summary
| Reporting metrics | detail |
| base year | 2023 |
| forecast period | 2023-2030 |
| Base year market size | $6.5 billion |
| Market size forecast | $9.5 billion |
| growth rate | 5.6% |
| Dominate the market segment | Hospital |
| Advantage area | North America |
| Key market drivers |
|
| Company Profile |
|
Explore more about this report – https://store.rationalstat.com/store/global-hepatitis-b-vaccine-recombinant-market/#tab-ux_global_tab
Competition Analysis and Market Structure
Some leading companies adopt various strategies to consolidate their market share and gain a competitive advantage over other competitors in the market. Mergers and acquisitions, partnerships and collaborations, and product launches are some of the strategies followed by industry players. Some of the key developments in the global hepatitis B vaccine (recombinant) market include.
- In January 2021, Gilead Sciences and Vir Biotechnology Inc collaborated to develop a new combination drug to treat people infected with the hepatitis B virus. The primary goal of this collaboration is to explore various potential treatment combinations for the development of novel hepatitis B vaccines.
Some of the prominent players and vendors significantly contributing to the growth of the global Hepatitis B Vaccine (Recombinant) market include Bharat Biotech International Ltd., CSL Ltd., Dynavax Technologies Corp, Emergent BioSolutions Inc., GlaxoSmithKline PLC, KM Biologics (Meiji Holdings Co., Ltd.), LG Chem Ltd., Merck & Co., Inc., Novartis AG, and Pfizer, Among other things.
Get free samples – https://store.rationalstat.com/store/global-hepatitis-b-vaccine-recombinant-market/#tab-ux_global_tab
RationalStat breaks down the global Hepatitis B vaccine (recombinant) Market based on type, application, distribution channel, and region
- Global Hepatitis B vaccine (recombinant) market Value (USD Million), Volume (Units) and Market Share (2019-2030) Analysis by Type
- Global Hepatitis B vaccine (recombinant) market Value (USD Million), Volume (Units) and Market Share (2019-2030) Analysis by Application
- Global Hepatitis B vaccine (recombinant) market Value (USD Million), Volume (Units) and Market Share (2019-2030) Analysis by Distribution Channel
- Hospital
- retail pharmacy
- government supplies
- Global Hepatitis B vaccine (recombinant) market Value (USD Million), Volume (Units) and Market Share Analysis by Region (2019-2030)
- North America Hepatitis B Vaccine (Recombinant) Market
- Latin America Hepatitis B Vaccine (Recombinant) Market
- Brazil
- Mexico
- Rest of Latin America
- Western Europe Hepatitis B Vaccine (Recombinant) Market
- Germany
- U.K.
- France
- Spain
- Italy
- Benelux
- Nordic
- Rest of Western Europe
- Eastern Europe Hepatitis B Vaccine (Recombinant) Market
- Russia
- Poland
- Hungary
- Other CIS countries
- Rest of Eastern Europe
- Asia Pacific Hepatitis B Vaccine (Recombinant) Market
- China
- Japan
- India
- South Korea
- Australia
- ASEAN
- Indonesia
- Thailand
- the Philippines
- Vietnam
- Malaysia
- Other ASEAN countries
- Rest of Asia Pacific
- Middle East and Africa Hepatitis B Vaccine (Recombinant) Market
- gulf cooperation council
- Saudi Arabia (KSA)
- United Arab Emirates (UAE)
- Other GCC countries
- South Africa
- Nigeria
- turkey
- Middle East and Rest of Africa
- gulf cooperation council
More information about this report – https://store.rationalstat.com/store/global-hepatitis-b-vaccine-recombinant-market/
Key questions answered in the Hepatitis B Vaccine (Recombinant) report:
- What will be the market value of the global hepatitis B vaccine (recombinant) market by 2030?
- What is the market size of the global Hepatitis B Vaccine (Recombinant) market?
- What are the market drivers for the global Hepatitis B Vaccine (Recombinant) market?
- What are the key trends in the global Hepatitis B Vaccine (Recombinant) market?
- Which is the leading region in the global Hepatitis B Vaccine (Recombinant) market?
- What are the major companies operating in the global Hepatitis B Vaccine (Recombinant) market?
- What is the market share of major segments in the global Hepatitis B Vaccine (Recombinant) market?
Running year-end discount of 20%-https://store.rationalstat.com/store/global-hepatitis-b-vaccine-recombinant-market/#tab-ux_global_tab
Explore our trend reports
research methodology
RationalStat has developed a state-of-the-art research methodology to process data and provide clients with the best real-time insights. We combine various industry experience, data analysis and expert opinions to create research methodologies for market sizing and forecasting.
RationalStat combines secondary sources and primary research to assess market size and develop forecasts. The key steps involved in deriving accurate market data are:
- Define the problem by understanding the type of market and the data your customers need.
- Data collection and collection is conducted through relevant paid databases, public sources, company reports, annual reports, surveys and interviews.
- Develop hypotheses to create market data, forecasts, influencing factors and their correlations.
- Evaluate and analyze data by reference to the data sources used and utilized.
- Validate, interpret and finalize data with the help of experienced analysts incorporating detailed information collected from primary and secondary sources.
Download key insights and market data – Ask a query
About RationalStat LLC
RationalStat is an end-to-end global market intelligence and consulting company, providing comprehensive market research reports, customized strategies and consulting studies. The company has sales offices in India, Mexico and the United States to support global and diversified operations. The company has more than 80 consultants and industry experts who have produced more than 850 market studies and industry reports. report store Per year.
RationalStat has strategic partnerships with leading data analytics and consumer research companies to meet customer needs. Other services provided by the company include consumer research, country reporting, risk reporting, valuation and advisory, financial research, due diligence, procurement and supply chain research, data analytics and analytical dashboards.
touch
RationalStat LLC
Kimberly Shaw,
Content and News Manager
sales@rationalstat.com
USA phone: +1 302 803 5429
UK phone: +44 203-287-1245
LinkedIn | Facebook | Twitter | Instagram | interest
